JP2023513004A5 - - Google Patents
Info
- Publication number
- JP2023513004A5 JP2023513004A5 JP2022545976A JP2022545976A JP2023513004A5 JP 2023513004 A5 JP2023513004 A5 JP 2023513004A5 JP 2022545976 A JP2022545976 A JP 2022545976A JP 2022545976 A JP2022545976 A JP 2022545976A JP 2023513004 A5 JP2023513004 A5 JP 2023513004A5
- Authority
- JP
- Japan
Links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US202062967416P | 2020-01-29 | 2020-01-29 | |
| US62/967,416 | 2020-01-29 | ||
| PCT/US2021/015695 WO2021155137A1 (en) | 2020-01-29 | 2021-01-29 | Modified adeno-associated viral capsid proteins for ocular gene therapy and methods of use thereof |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2023513004A JP2023513004A (ja) | 2023-03-30 |
| JP2023513004A5 true JP2023513004A5 (https=) | 2024-02-02 |
| JPWO2021155137A5 JPWO2021155137A5 (https=) | 2024-02-02 |
Family
ID=74673421
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2022545976A Pending JP2023513004A (ja) | 2020-01-29 | 2021-01-29 | 眼科遺伝子療法のための改変されたアデノ随伴ウイルスカプシドタンパク質およびその使用方法 |
Country Status (15)
| Country | Link |
|---|---|
| US (1) | US20210261625A1 (https=) |
| EP (1) | EP4097121A1 (https=) |
| JP (1) | JP2023513004A (https=) |
| KR (1) | KR20220133941A (https=) |
| CN (1) | CN115989234A (https=) |
| AR (1) | AR121228A1 (https=) |
| AU (1) | AU2021213786A1 (https=) |
| BR (1) | BR112022014852A2 (https=) |
| CA (1) | CA3165019A1 (https=) |
| CO (1) | CO2022010227A2 (https=) |
| IL (1) | IL294868A (https=) |
| MX (1) | MX2022009252A (https=) |
| PH (1) | PH12022551878A1 (https=) |
| TW (1) | TW202142552A (https=) |
| WO (1) | WO2021155137A1 (https=) |
Families Citing this family (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| MX2024004217A (es) | 2021-10-08 | 2024-06-26 | Dyno Therapeutics Inc | Variantes de cápside y métodos de uso de estas. |
| EP4551253A1 (en) | 2022-07-08 | 2025-05-14 | Ospedale San Raffaele S.r.l. | Transgene cassettes |
| EP4303226A1 (en) | 2022-07-08 | 2024-01-10 | Ospedale San Raffaele S.r.l. | Transgene cassettes and epigenetic silencers for the treatment of disorders |
| KR102901502B1 (ko) | 2024-06-27 | 2025-12-18 | 이엔셀 주식회사 | 안구 세포 또는 조직을 표적하는 펩타이드 및 이를 포함하는 바이러스 캡시드 단백질 및 바이러스 벡터 |
Family Cites Families (18)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| AU722624B2 (en) | 1996-09-06 | 2000-08-10 | Trustees Of The University Of Pennsylvania, The | An inducible method for production of recombinant adeno-associated viruses utilizing T7 polymerase |
| US6225291B1 (en) | 1997-04-21 | 2001-05-01 | University Of Florida | Rod opsin mRNA-specific ribozyme compositions and methods for the treatment of retinal diseases |
| US6995006B2 (en) | 1997-09-05 | 2006-02-07 | Targeted Genetics Corporation | Methods for generating high titer helper-free preparations of released recombinant AAV vectors |
| US6566118B1 (en) | 1997-09-05 | 2003-05-20 | Targeted Genetics Corporation | Methods for generating high titer helper-free preparations of released recombinant AAV vectors |
| US6723551B2 (en) | 2001-11-09 | 2004-04-20 | The United States Of America As Represented By The Department Of Health And Human Services | Production of adeno-associated virus in insect cells |
| DE602004030327D1 (de) | 2003-05-21 | 2011-01-13 | Genzyme Corp | Verfahren zur herstellung von präparationen rekombinanter aav-virionen, die weitgehend frei von leeren capsiden sind |
| DK2191001T3 (en) | 2007-04-09 | 2016-09-19 | Univ Florida | RAAV VECTOR COMPOSITIONS WITH TYROSIN MODIFIED CAPSIDE PROTEINS AND PROCEDURES FOR USE THEREOF |
| US20100081707A1 (en) | 2008-02-21 | 2010-04-01 | Ali Robin R | Devices and methods for delivering polynucleotides into retinal cells of the macula and fovea |
| HUE028341T2 (en) | 2009-06-16 | 2016-12-28 | Genzyme Corp | Improved methods for purification of recombinant aav vectors |
| EP2826860B1 (en) | 2010-04-23 | 2018-08-22 | University of Massachusetts | CNS targeting AAV vectors and methods of use thereof |
| WO2012109570A1 (en) * | 2011-02-10 | 2012-08-16 | The University Of North Carolina At Chapel Hill | Viral vectors with modified transduction profiles and methods of making and using the same |
| GB201403684D0 (en) * | 2014-03-03 | 2014-04-16 | King S College London | Vector |
| FI3628334T3 (fi) * | 2014-03-21 | 2023-09-15 | Genzyme Corp | Geenihoito verkkokalvon pigmenttirappeuma |
| IL248102B (en) * | 2014-05-02 | 2022-07-01 | Genzyme Corp | aav vectors for gene therapy of the central nervous system and retina |
| AU2015335923B2 (en) * | 2014-10-21 | 2021-04-29 | University Of Massachusetts | Recombinant AAV variants and uses thereof |
| NZ791267A (en) | 2016-08-15 | 2025-11-28 | Genzyme Corp | Methods for detecting AAV |
| US20190262373A1 (en) * | 2016-08-16 | 2019-08-29 | The University Of North Carolina At Chapel Hill | Methods and compositions for targeted gene transfer |
| US12338267B2 (en) * | 2018-05-15 | 2025-06-24 | President And Fellows Of Harvard College | Viral vectors exhibiting improved gene delivery properties |
-
2021
- 2021-01-29 US US17/162,356 patent/US20210261625A1/en active Pending
- 2021-01-29 MX MX2022009252A patent/MX2022009252A/es unknown
- 2021-01-29 AU AU2021213786A patent/AU2021213786A1/en active Pending
- 2021-01-29 AR ARP210100248A patent/AR121228A1/es unknown
- 2021-01-29 PH PH1/2022/551878A patent/PH12022551878A1/en unknown
- 2021-01-29 TW TW110103551A patent/TW202142552A/zh unknown
- 2021-01-29 CA CA3165019A patent/CA3165019A1/en active Pending
- 2021-01-29 KR KR1020227029428A patent/KR20220133941A/ko active Pending
- 2021-01-29 CN CN202180011349.3A patent/CN115989234A/zh active Pending
- 2021-01-29 JP JP2022545976A patent/JP2023513004A/ja active Pending
- 2021-01-29 WO PCT/US2021/015695 patent/WO2021155137A1/en not_active Ceased
- 2021-01-29 EP EP21707556.3A patent/EP4097121A1/en active Pending
- 2021-01-29 BR BR112022014852A patent/BR112022014852A2/pt unknown
- 2021-01-29 IL IL294868A patent/IL294868A/en unknown
-
2022
- 2022-07-19 CO CONC2022/0010227A patent/CO2022010227A2/es unknown